QT Imaging and Olea Medical Forge Alliance for AI-Powered Breast Health

NOVATO, Calif. – January 27, 2026 – QT Imaging Holdings, Inc., a company pioneering radiation-free breast imaging, has announced a significant collaboration with Olea Medical, a Canon Medical Systems company renowned for its advanced medical imaging software. The partnership aims to integrate Olea's sophisticated visualization and quantitative analytics into QT Imaging's cloud platform, creating a powerful, next-generation ecosystem for breast health management.

This strategic alliance is set to enhance QT Imaging’s innovative Breast Acoustic CT™ system by embedding Olea’s AI-ready technologies. The goal is to provide clinicians with superior tools for clinical interpretation, streamline research workflows, and unlock deeper insights through quantitative analysis, potentially transforming the landscape of breast cancer detection and diagnosis.

A New Frontier in Radiation-Free Diagnostics

At the heart of this collaboration is QT Imaging's Breast Acoustic CT™ technology, a system that has been gaining traction as a formidable alternative to traditional mammography. Unlike mammograms, which use X-rays, the QTscan uses low-frequency sound waves, eliminating patient exposure to ionizing radiation. This is a crucial advantage, particularly for younger women or those with risk factors who may require more frequent screening but are concerned about cumulative radiation doses.

Clinical studies have validated the system's effectiveness. A notable study published in Academic Radiology found that QT Imaging's technology was statistically non-inferior to 3D mammography (DBT) in detecting breast lesions. Furthermore, the system demonstrated high specificity in identifying benign cysts, a capability that could significantly reduce the rate of unnecessary patient recalls, thereby lowering both healthcare costs and patient anxiety.

The patient experience is also a key differentiator. The procedure avoids the painful breast compression required for mammography, offering a more comfortable and less invasive screening process. This focus on patient comfort and safety, combined with strong clinical performance, has fueled the company's growth. QT Imaging has seen a substantial increase in revenue, driven by scanner shipments and a strategic focus on building a recurring revenue model through its cloud services.

The Power of Advanced Analytics and AI

The collaboration injects Olea Medical's formidable software expertise into QT Imaging’s hardware innovation. Olea Medical is a recognized leader in post-processing solutions, providing vendor-neutral, AI-assisted tools that extract quantitative and qualitative information from medical images across modalities like MR, CT, and ultrasound.

By integrating Olea's technologies, the QT Imaging platform will gain advanced capabilities for segmentation and volumetric analysis. These tools allow for more precise measurement and characterization of potential lesions, improving diagnostic confidence and clinical efficiency. As part of the agreement, QT Imaging will distribute the 'QT Imaging Olea Vision software,' a highly customizable 3D and 4D DICOM viewer designed for intuitive navigation and advanced image manipulation.

“Our collaboration with Olea Medical strengthens the clinical visualization and analytical capabilities of QT Imaging’s cloud platform,” said Dr. Raluca Dinu, Chief Executive Officer of QT Imaging. “Together with the enterprise delivery infrastructure we are putting in place, this collaboration supports our mission to deliver advanced, quantitative breast imaging at scale for both research and clinical care.”

This sentiment was echoed by Olea Medical's leadership, who see the partnership as a fusion of shared values.

“We are pleased to collaborate with QT Imaging to bring our advanced visualization and quantitative imaging expertise into next-generation breast imaging,” said Dr. Faycal Djeridane, Founder and CEO of Olea Medical. “This collaboration reflects a shared commitment to clinically meaningful innovation, multimodality integration and quantitative imaging.”

Building an Integrated, Cloud-Powered Ecosystem

A cornerstone of this initiative is the use of a unified, cloud-based platform. The collaboration enhances QT Imaging’s existing Cloud SaaS Platform, which is built upon the InteleShare enterprise PACS backbone. This architecture is designed for secure, scalable delivery of medical imaging studies and analytics.

The most significant clinical advantage of this integrated ecosystem is its support for a multimodality approach. Radiologists will be able to view and analyze QT Imaging's acoustic CT studies alongside traditional images from mammography, digital breast tomosynthesis (DBT), ultrasound, and MRI, all within a single, unified interface. This holistic view provides a more comprehensive understanding of breast tissue, enabling clinicians to correlate findings across different imaging types for a more nuanced and confident diagnosis.

From an operational standpoint, the cloud platform enables secure, network-enabled access that facilitates multi-institutional collaboration, centralized research workflows, and standardized support for clinical trials. This scalability is crucial for QT Imaging's goal to expand the adoption of its technology globally and aligns with the broader industry trend of moving medical diagnostics to flexible, accessible cloud environments. It also strengthens QT Imaging's business model by bolstering its Software as a Service (SaaS) offerings, a key source of anticipated recurring revenue.

Redefining the Patient and Clinician Experience

Ultimately, the success of this collaboration will be measured by its impact on patients and the clinicians who care for them. For patients, the combination of radiation-free, compression-free imaging with analytics that can reduce false positives promises a less stressful and safer screening experience. This could improve adherence to screening guidelines and lead to earlier detection of disease.

For radiologists and oncologists, the integrated platform offers a significant leap in workflow efficiency and diagnostic power. By automating routine tasks and providing advanced quantitative tools within an intuitive, multimodality viewer, the system allows clinicians to focus their expertise on complex analysis rather than manual data manipulation. The ability to compare different types of scans side-by-side enhances diagnostic precision and supports better-informed treatment planning.

This partnership represents a convergence of key trends in modern medicine: the shift toward safer, non-invasive diagnostics; the integration of artificial intelligence and advanced analytics; and the leveraging of cloud computing to make powerful tools widely accessible. By combining their respective strengths, QT Imaging and Olea Medical are not just enhancing a product but are building a comprehensive platform poised to support a new standard of care. This strategic alignment aims to accelerate the shift toward a more precise, patient-centric, and data-driven future in breast health management.